Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in Japan-Reference-Cited by-同舟云学术

Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in Japan

Published:2013-09-10 Issue:4 Volume:19 Page:679-685
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Miyake Hideaki,Harada Ken-ichi,Kumano Masafumi,Fujisawa Masato

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-013-0617-7.pdf

Reference25 articles.

1. Parton M, Gore M, Eisen T (2006) Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer. J Clin Oncol 24:5584–5592

2. Bellmunt J, Montagut C, Albiol S et al (2007) Present strategies in the treatment of metastatic renal cell carcinoma: an update on molecular targeting agents. BJU Int 99:274–280

3. Chowdhury S, Larkin JM, Gore ME (2008) Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies. Eur J Cancer 44:2152–2162

4. Fasolo A, Sessa C (2012) Targeting mTOR pathways in human malignancies. Curr Pharm Des 18:2766–2777

5. Sheppard K, Kinross KM, Solomon B et al (2012) Targeting PI3 kinase/AKT/mTOR signaling in cancer. Crit Rev Oncog 17:69–95

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of acute oral mucosal damage secondary to the use of systemic antineoplastics: A systematic review and meta-analysis;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-03

2. Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance study;Japanese Journal of Clinical Oncology;2020-05-27

3. Oral stomatitis and mTOR inhibitors: A review of current evidence in 20,915 patients;Oral Diseases;2018-02-26

4. A case of metastatic renal cell carcinoma showing complete remission after cytoreductive nephrectomy followed by temsirolimus;International Cancer Conference Journal;2016-09-02

5. Effect of Targeting Clusterin Using OGX-011 on Antitumor Activity of Temsirolimus in a Human Renal Cell Carcinoma Model;Targeted Oncology;2016-08-15